Newsletter | January 27, 2016

1.27.2016 -- Combination Product Insights Special Edition

 
Biosimilar Development
 
Keeping The Patient At The Center Of Drug Delivery Devices
By Bill Welch, Chief Technology Officer, Phillips-Medisize   By Bill Welch, Chief Technology Officer, Phillips-Medisize
Healthcare is increasingly moving out of the hospital and into the home as self-administration of medications becomes more cost-effective. As the population ages, and people live longer with chronic conditions, the need for safe and effective drug delivery devices will continue to increase.
6 Guidelines To Follow When Developing Combination Products
By Winston Brown, VP of Global Quality, Phillips-Medisize   By Winston Brown, VP of Global Quality, Phillips-Medisize
While the development of a combination product comes with significant patient benefits through technology and molecule innovation, that reward can be offset by the range of regulatory complexity and uncertainty encountered with bringing a product to market, in addition to any post-marketing activities.
Insiders' Guide To Winning In the Drug Delivery Device Market — Part 1: Design
By Doug Roe, Chief Editor   By Doug Roe, Chief Editor
As challenges continue to mount in the med device industry, many companies are looking to drug delivery as a new revenue stream. Here, Neil Cammish, technical director, International Device Solutions, discusses the drug delivery technologies poised to have a market impact in 2016 and beyond.
Human-Centered Design And Inhalation Device Development
By Bill Welch, Chief Technology Officer, Phillips-Medisize   By Bill Welch, Chief Technology Officer, Phillips-Medisize
Human-centered designs have become a driving trend in the development of next-generation inhalation devices, making them more useful, usable, and desirable than current inhalation devices. By applying design research, industrial research, and human factor disciplines in cooperation with design for manufacturing and assembly philosophy, patients are able to receive inhalation devices that minimize opportunities for error, and support greater adherence to their prescribed therapy.
The Next Generation Drug Delivery Devices
  An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders.